CA2432945C - Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical - Google Patents
Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical Download PDFInfo
- Publication number
- CA2432945C CA2432945C CA002432945A CA2432945A CA2432945C CA 2432945 C CA2432945 C CA 2432945C CA 002432945 A CA002432945 A CA 002432945A CA 2432945 A CA2432945 A CA 2432945A CA 2432945 C CA2432945 C CA 2432945C
- Authority
- CA
- Canada
- Prior art keywords
- surgery
- pyridoxine hydrochloride
- doxylamine succinate
- medicament
- post
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002432945A CA2432945C (fr) | 2003-07-10 | 2003-07-10 | Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002432945A CA2432945C (fr) | 2003-07-10 | 2003-07-10 | Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2432945A1 CA2432945A1 (fr) | 2003-09-28 |
CA2432945C true CA2432945C (fr) | 2004-11-23 |
Family
ID=28796494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002432945A Expired - Fee Related CA2432945C (fr) | 2003-07-10 | 2003-07-10 | Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2432945C (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2761212A1 (fr) * | 2011-12-07 | 2013-06-07 | Pharmascience Inc. | Formulation de pyridoxine et de doxylamine a action retardee sans delitant et son procede de fabrication |
US10500196B2 (en) | 2015-08-17 | 2019-12-10 | Alpha To Omega Pharmaceutical Consultants, Inc. | Transdermal and/or topical delivery systems composed of doxylamine succinate and pyridoxine hydrochloride in combination, or alone |
AR121619A1 (es) * | 2020-03-25 | 2022-06-22 | Inibsa Ginecologia S A | Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación |
WO2023101620A1 (fr) * | 2021-11-30 | 2023-06-08 | Ilko Ilac Sanayi Ve Ticaret A.S. | Composition à libération retardée comprenant de la doxylamine et de la pyridoxine |
-
2003
- 2003-07-10 CA CA002432945A patent/CA2432945C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2432945A1 (fr) | 2003-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20130045241A (ko) | 구토방지제로서의 아미설프라이드의 용도 | |
US7638516B2 (en) | Agent for therapeutic treatment of optic nerve diseases and the like | |
US20230364115A1 (en) | Novel psychedelic compositions, delivery systems and therapeutic uses thereof | |
Tarkkila et al. | Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine | |
US7259180B2 (en) | Methods and compositions for treatment of macular and retinal disease | |
US20230138114A1 (en) | Treatment of hand eczema | |
CA2432945C (fr) | Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical | |
US20090203727A1 (en) | Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion | |
EP0689437B1 (fr) | Utilisation de granisetron dans le traitement de la nausee et des vomissements postoperatoires | |
US20120122919A1 (en) | Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist | |
US20050004181A1 (en) | Use of anti-emetic for pre and post operative care | |
KR20180066780A (ko) | 뇌종양의 예방 또는 치료용 약학 조성물 | |
KR20200026118A (ko) | 헬리코박터 파일로리 제균용 조성물 | |
US20050234063A1 (en) | Therapeutic agent for brain hemorrhage | |
US20110195987A1 (en) | Treatment with cholinergic agonists | |
NZ249197A (en) | Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine in the preparation of medicaments for the treatment or prophylaxis of pain and/or oedema | |
EP2727595B1 (fr) | Composition pharmaceutique pour traiter l'éjaculation prématurée et procédé pour traiter l'éjaculation prématurée | |
CN115475165B (zh) | 马来酸茚达特罗在出血性脑损伤相关疾病中的应用 | |
EP2043669A2 (fr) | Compositions et procédés destinés au traitement et à la prévention d'un reflux gastro- sophagien pathologique | |
KR20190021180A (ko) | 퇴행성 신경질환 치료용 복합 제형 조성물 | |
KR102222271B1 (ko) | 펙소페나딘 가용화 조성물 | |
US20070093519A1 (en) | Anti-emetic uses of cannabinoid analogs | |
WO1998038997A1 (fr) | Utilisation de la levobupivacaine en association avec des opioides ou des alfa2-agonistes comme anesthesiants ou analgesiques | |
US6162792A (en) | Use of spiramycin for treating gastrointestinal disorders caused by H. pylori | |
WO2024033946A1 (fr) | Compositions et utilisation dans des méthodes de traitement d'un déficit cognitif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20180710 |